Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Garrison Michael David has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 25, 2026.
On the most recent filing, Garrison Michael David is listed as EVP & Pres Med.Essntl&BioPharm at BECTON DICKINSON & CO. Inside the rolling window, Garrison Michael David reported no open-market purchases and 4 open-market sales totaling $784K in BDX. The largest disclosed transaction in the window is a sale of 1,610 BDX shares on Jan 15, 2026, worth $334K.
Companies traded
Other insiders at BDX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$784K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Garrison Michael David made?
Garrison Michael David has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Garrison Michael David trade?
Garrison Michael David has filed SEC Form 4 disclosures for 1 company, including BDX.
When was Garrison Michael David's most recent SEC Form 4 filing?
Garrison Michael David's most recent SEC Form 4 filing on Tracefour is dated Jun 25, 2026.
What is Garrison Michael David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Garrison Michael David is listed as EVP & Pres Med.Essntl&BioPharm.
What is Garrison Michael David's total buy and sell value in the current window?
Inside the rolling retention window, Garrison Michael David bought $0 and sold $784K based on SEC Form 4 filings.
What was Garrison Michael David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,610 BDX shares on 2026-01-15, worth $334K, per SEC Form 4 filings.